Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease.
Javier Lozano-SanromaAlberto BarrosIgnacio AlcaldeRosa Alvarado-VillacortaRonald M Sánchez-ÁvilaJuan Queiruga-PiñeiroLuis Fernández-Vega CuetoEduardo AntiuaJesús Merayo-LlovesPublished in: Diseases (Basel, Switzerland) (2024)
The use of PRGF in patients with congenital aniridia and ocular dryness symptoms led to significant improvements in symptomatology, ocular redness, and ocular damage. No adverse effects were observed during the use of PRGF.
Keyphrases